40116729 2025-01-01 2025-12-31 40116729 2025-01-01 2025-12-31 1 40116729 2025-01-01 2025-12-31 2 40116729 2025-01-01 2025-12-31 1 40116729 2024-01-01 2024-12-31 40116729 2025-12-31 40116729 2024-12-31 40116729 2025-01-01 c:ContributedCapitalMember 40116729 2025-01-01 c:RetainedEarningsMember 40116729 2025-01-01 c:ProposedDividendRecognisedInEquityMember 40116729 2025-01-01 2025-12-31 c:ProposedExtraordinaryDividendRecognisedInEquityMember 40116729 2025-01-01 2025-12-31 c:RetainedEarningsMember 40116729 2025-01-01 2025-12-31 c:ProposedDividendRecognisedInEquityMember 40116729 2025-12-31 c:ContributedCapitalMember 40116729 2025-12-31 c:RetainedEarningsMember 40116729 2025-12-31 c:ProposedDividendRecognisedInEquityMember iso4217:DKK xbrli:pure true BDO Statsautoriseret Revisionspartnerselskab Havneholmen 2, 6. sal DK-2450 Copenhagen SV 45719375 2026-05-22 Kevin Douglas Mc Clelland Årsrapport Human Active Technology Holding ApS Ellehaven 6 5900 Rudkøbing Den uafhængige revisors erklæring om udvidet gennemgang 40116729 2018-12-20 Langeland 2025-01-01 2025-12-31 2024-01-01 2024-12-31 BDO Statsautoriseret Revisionspartnerselskab Havneholmen 2, 6. sal 2450 Copenhagen SV Danske Bank A/S Holmens Kanal 2-12 1092 Copenhagen K Today the Executive Board have discussed and approved the Annual Report of Human Active Technology Holding ApS for the fi­nan­ci­al year 1 January  - 31 December 2025. The Annual Report is presented in accor­dance with the Da­nish Fi­nan­ci­al State­ments Act. In our opinion the Fi­nan­ci­al Sta­te­ments give a true and fair view of the Company's assets, liabilities and financial position at 31 December 2025 and of the results of the Company's operations for the fi­nan­ci­al year 1 January  - 31 December 2025. The Management Commentary includes in our opinion a fair presentation of the matters dealt with in the Commentary. We recommend the Annual Report be approved at the Annual General Meeting. Rudkøbing 2026-05-22 Kevin Douglas McClelland Chad Michael Hammerly To the Shareholder of Human Active Technology Holding ApS Konklusion We ha­ve per­for­med an extended review of the Fi­nan­ci­al Sta­te­ments of Human Active Technology Holding ApS for the fi­nan­ci­al year 1 January - 31 December 2025, which comprise income statement, Balance Sheet, sta­te­ment of chan­ges in e­qui­ty and no­tes, including a summary of significant accounting policies. The Fi­nan­ci­al Sta­te­ments are pre­pared under the Danish Financial State­ments Act.   Based on the work performed in our o­pi­ni­on, the Fi­nan­ci­al Sta­te­ments gi­ve a true and fair vi­ew of the Com­pa­ny's financial position at 31 December 2025 and of the results of the Com­pa­ny's operations for the fi­nan­ci­al year 1 January - 31 December 2025 in accordance with the Danish Financial Statements Act.   Basis for ConclusionGrundlag for konklusion We conducted our extended review in accordance with the Danish Business Authority's Assurance Standard for Small Enterprises and FSR – Danish Auditors' standard on extended review of Financial Statements prepared in accordance with the Danish Financial Statements Act. Our responsibilities under those standards and requirements are further described in the "Auditor's Responsibilities for the Extended Review of the Fi­nan­ci­al Sta­te­ments” section of our report. We are independent of the Com­pa­ny in accordance with the International Ethics Standards Board for Accountants’ International Code of Ethics for Professional Accountants (including International Independence Standards) (IESBA Code), together with the ethical requirements that are relevant to our audit of the Financial Statements in Denmark, and we have fulfilled our other ethical responsibilities in accordance with these requirements and the IESBA Code. We be­lie­ve that the e­vi­den­ce we ha­ve ob­tai­ned is suf­fi­ci­ent and ap­prop­ria­te to pro­vi­de a ba­sis for our con­clu­si­on.   Grundlag for konklusion Management's Re­spon­si­bi­li­ti­es for the Fi­nan­ci­al Sta­te­ments Management is responsible for the preparation of Fi­nan­ci­al Sta­te­ments that give a true and fair view in accordance with the Danish Financial Statements Act, and for such Internal control as Ma­na­ge­ment determines is necessary to enable the preparation of Fi­nan­ci­al Sta­te­ments that are free from material misstatement, whether due to fraud or error.   In preparing the Fi­nan­ci­al Sta­te­ments, Ma­na­ge­ment is responsible for assessing the Com­pa­ny's ability to continue as a going concern, disclosing, as applicable, matters related to going concern and using the going concern basis of accounting in preparing the Fi­nan­ci­al Sta­te­ments unless Management either intends to liquidate the Com­pa­ny or to cease operations, or has no realistic alternative but to do so.   Our responsibility is to express a conclusion on the Fi­nan­ci­al Sta­te­ments. This requires that we plan and perform procedures in order to obtain limited assurance for our conclusion on the Fi­nan­ci­al Sta­te­ments and in addition perform specifically required supplementary procedures to obtain further assurance for our conclusion.   An extended review comprises procedures that primarily consist of making inquiries of Ma­na­ge­ment and others within the Company, as appropriate, analytical procedures and the specifically required supplementary procedures as well as evaluation of the evidence obtained.   The procedures performed in an extended review are less than those performed in an audit, and accordingly, we do not express an audit opinion on the Fi­nan­ci­al Sta­te­ments.   Statement on the Management Commentary Management is responsible for the Ma­na­ge­ment Com­men­ta­ry.   Our conclusion on the Fi­nan­ci­al Sta­te­ments does not cover the Ma­na­ge­ment Com­men­ta­ry, and we do not express any form of assurance conclusion thereon.   In connection with our extended review of the Fi­nan­ci­al Sta­te­ments, our responsibility is to read the Ma­na­ge­ment Com­men­ta­ry and, in doing so, consider whether the Ma­na­ge­ment Com­men­ta­ry is materially inconsistent with the Fi­nan­ci­al Sta­te­ments or our knowledge obtained during the extended review, or otherwise appears to be materially misstated.   Moreover, it is our responsibility to consider whether the Ma­na­ge­ment Com­men­ta­ry provides the information required under the Danish Financial Statements Act.   Based on the work we have performed, we conclude that the Ma­na­ge­ment Com­men­ta­ry is in accordance with the Fi­nan­ci­al Sta­te­ments and has been prepared in accordance with the requirements of the Danish Financial Statements Act. We did not identify any material misstatement in the Ma­na­ge­ment Com­men­ta­ry.   Copenhagen 2026-05-22 BDO Statsautoriseret Revisionspartnerselskab 45719375 Søren Søndergaard Jensen Den uafhængige revisors erklæring om udvidet gennemgang State Authorised Public Accountant mne32069 Principal activities The primary activit for Human Active Technology Holding ApS is to hold shares in subsidiaries. Human active Technology Holding ApS holds all the shares in Human Active Technology ApS, Innovative Europe ApS and SIS-USA Inc.   The operating activities of the group comprise development, production and sale of advanced ergonomic high adjustable tables and monitor arms for the use in modern companies around the globe.   Significant events after the end of the financial year No events have occurred after the end of the financial year of material importance for the Company's financial position.   10336471 0 45466 25060 10291005 -25060 0 0 10291005 -25060 33103200 0 -22812195 -25060 10291005 -25060 11000000 33766729 11000000 33766729 11000000 33766729 15425 15425 15425 15425 15425 15425 11015425 33782154 51000 51000 10812784 33624979 10863784 33675979 12500 10500 139141 95675 151641 106175 151641 106175 11015425 33782154 DKKSha­re ca­pi­talRetained earningsProposed dividendTotal Equity at 1 January 202551.00033.624.979033.675.979 -33.103.200 Proposed profit allocation -22.812.19533.103.20010.291.005 Transactions with ownersExtraordinary dividend paid -33.103.200-33.103.200 Equity at 31 December 202551.00010.812.784010.863.784 51000 33624979 0 -33103200 -22812195 -33103200 51000 10812784 0 1 | Staff costs Ave­ra­ge num­ber of full ti­me em­ploy­ees11 1 1 3 | Charges and securities Human Active Technology Holding has provided a guarantee for Human Active Technology ApS's fulfillment of the lease agreement for the factory in Rudkøbing. The security amounts to DKK 2,094,000.00 plus VAT. 4 | Related parties The Company's related parties include: Controlling interest The company is included in the consolidated financial statements of Human Active Technology LLC, 100 Kuebler Road, Easton, PA18040, USA. Transactions with related parties The company did not carry out any material transactions that were not concluded on market conditions. According to section 98c, subsection 7 of the Danish Financial Statements Act information is given only on transactions that were not performed on common market conditions. The Annual Report of Human Active Technology Holding ApS for 2025 has been presented in accor­dance with the pro­vi­sions of the Da­nish Fi­nan­ci­al State­ments Act for en­ter­pri­ses in re­por­ting class B and cer­tain pro­vi­si­ons ap­ply­ing to re­por­ting class C.  Regnskabsklasse B1truetrueThe format of the income statement has been adjusted to the Company's activities as a holding Company.  The Annual Report is prepared consistently with the accounting principles applied last year.   Regnskabsklasse B true Income from investments in subsidiaries Dividend from equity interests is recognised in the financial year in which the dividend is declared. In connection with transfers, potential profits are recognised when the economic rights related to the sold equity interests are transferred, however, at the earliest when the profit has been realised or is regarded as realisable. Moreover, realised losses other than impairments are included where identified.   Other external expenses Other external expenses include cost of administration etc.    Tax The tax for the year, which consists of the current tax for the year and changes in deferred tax, is recognised in the Income Statement by the share that may be attributed to the profit for the year, and is recognised directly in equity by the share that may be attributed to entries directly to equity.   Financial non-current assets Equity investments in Financial non-current assets are measured at cost. If the cost exceeds the net realisable value, this is written down to the lower value.  The combination method is applied when acquiring enterprises within the Group, where the combination is regarded as completed at the date of acquisition, and by using the carrying amounts of the assets and liabilities acquired. The difference between the acquisition cost and carrying amounts is recognised directly in equity.   Impairment of fixed assets The carrying amount of fixed assets are valued on an annual basis for indications of impairment other than that reflected by amortisation and depreciation.   In the event of impairment indications, an impairment test is made for each asset or group of assets, respectively. If the recoverable amount is lower than the carrying amount, the asset is written down to the carrying amount.   The recoverable amount is calculated at the higher of net selling price and capital value. The capital value is determined as the fair value of the expected net cash flows from the use of the asset or group of assets and the expected net cash flows from sale of the asset or group of assets after the end of its useful life.   Receivables Receivables are measured at amortised cost which usually corresponds to nominal value. The value is written down to meet expected losses.   Write-off is performed to provide for losses when an objective indication has been assessed to have incurred that a receivable or a portfolio of receivables are impaired. If there is an objective indication that an individual receivable is impaired, the write-off is performed at individual level.   Receivables for which there are no objective indication of impairment at individual level are assessed at portfolio level for objective indication of impairment. The portfolios are primarily based on the debtors’ registered office and credit rating in accordance with the Company’s policy for credit risk management. The objective indicators, which are applied for portfolios, are determined based on the historical loss experiences.   Write-off is determined as the difference between the carrying amount of receivables and the present value of the expected cash flows, including realisable value of any received collaterals. The effective interest rate is used as discount rate for the single receivable or portfolio.   Tax payable and deferred tax Current tax liabilities and receivable current tax are recognised in the Balance Sheet as the calculated tax on the taxable income for the year, ad­justed for tax on the taxable income for previous years and taxes paid on account.   Deferred tax is measured on the temporary dif­ferences between the carrying amount and the tax value of assets and liabilities.   Deferred tax assets, including the tax value of tax loss carryforwards, are measured at the amount at which the asset is expected to be used within a reasonable number of years, either by setoff against tax on future earnings or by setoff against deferred tax liabilities within the same legal tax entity.   Deferred tax is measured on the basis of the tax rules and tax rates that under the legislation in force on the Balance Sheet date will be ap­pli­cable when the deferred tax is expected to crystallise as current tax. Any changes in the deferred tax resulting from changes in tax rates, are recognised in the income statement, except from items recognised directly in equity.   Liabilities Financial liabilities are recognised at the time of borrowing by the amount of proceeds received less transaction costs. In subsequent periods, the financial liabilities are measured at amortised cost equal to the capitalised value when using the effective interest, the difference between the proceeds and the nominal value being recog­nised in the Income Statement over the loan period.   The amortised cost of current liabilities corresponds usually to the nominal value.